Mallinckrodt divests hemostasis portfolio for $185M

In an effort to refine its pipeline, specialty pharmaceutical company Mallinckrodt plc (NYSE:MNK) sold surgical site bleeding products Preveleak Surgical Sealant and

Read the full 224 word article

User Sign In